Text and Data Mining valid from 2018-04-03
Received: 27 September 2017
Accepted: 26 March 2018
First Online: 3 April 2018
Ethics approval and consent to participate
: The present study is a post hoc analysis of a randomized, multicentre, non-inferiority, phase 3 trial which was already published (Hofheinz RD, Wenz F, Post S, et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.Lancet Oncol2012; 13: 579–88.). The trial has been registered withExternalRef removednumber NCT01500993. An ethical approval has been obtained for this trial from the 2nd Ethics Committee of the Medical Faculty of Mannheim, Germany. Therefore no supplementary ethical approval has been obtained for the present study.
: Not applicable
: The authors declare that they have no competing interests
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.